Article: Oral Treatment for Male Pattern Hair Loss Shows Promise; Research Results Indicate Propecia(TM) Increases Scalp Hair Growth in Men

SAN FRANCISCO, March 23 /PRNewswire/ -- New data on Propecia (finasteride 1 mg), Merck & Co., Inc.'s (NYSE: MRK) investigational oral treatment for men with male pattern hair loss, show it increased hair growth significantly in a majority of treated men. Results were announced today at the annual meeting of the American Academy of Dermatology.

Phase III clinical trials presented today consisted of two large, multicenter, placebo-controlled studies of 1,553 men with male pattern hair loss. Men in clinical trials had mild-to-moderate, but not complete, hair loss. They received either oral Propecia once daily or placebo for one year.

Scalp hair ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!